Companies by Sector - Pharmaceuticals and Biotechnology
| EPIC | Company | Index | Dividend Yield | Market Cap | Price Close | % Change |
|---|---|---|---|---|---|---|
| AZN | AstraZeneca | FTSE 100 | 2.00 | £181.6B | 12,154.00 | 3.81% |
| GSK | GSK | FTSE 100 | 3.87 | £71.62B | 1,854.50 | 4.74% |
| HLN | Haleon | FTSE 100 | 2.04 | £29.36B | 342.20 | 2.52% |
| HIK | Hikma Pharmaceuticals | FTSE 250 | 3.87 | £3.2B | 1,544.00 | 0.85% |
| HCM | Hutchmed China | AIM | £1.67B | 199.00 | 4.80% | |
| INDV | Indivior | FTSE 250 | £1.54B | 1,238.00 | -3.10% | |
| GNS | Genus | FTSE 250 | 1.63 | £1.44B | 2,134.00 | -1.30% |
| OXB | Oxford BioMedica | FTSE Small Cap | £536.86M | 440.00 | -0.79% | |
| AVCT | Avacta Group | AIM | £341.94M | 75.50 | -7.00% | |
| AGY | Allergy Therapeutics | AIM | £300.8M | 4.70 | -2.50% | |
| PRTC | Puretech Health | FTSE Small Cap | £292.74M | 119.40 | 0.00% | |
| ANCR | Animalcare Group | AIM | 0.66 | £231.3M | 335.00 | -2.60% |
| BTG | BTG | AIM | 4.18 | £171.06M | 107.00 | -0.10% |
| MXCT | Maxcyte Inc | AIM | £161.75M | 147.69 | -1.20% | |
| BMK | Benchmark Holdings | AIM | £135.69M | 22.05 | 1.50% | |
| DXRX | Diaceutics | AIM | £134.11M | 161.40 | -0.50% | |
| SCLP | Scancell Holdings | AIM | £123.04M | 10.00 | -1.10% | |
| ANP | Anpario | AIM | 2.65 | £93.06M | 455.00 | -0.90% |
| BVXP | Bioventix | AIM | 8.78 | £83.6M | 1,510.00 | -2.20% |
| 4BB | 4basebio | AIM | £74.58M | 480.00 | -0.40% | |
| FARN | Faron Pharmaceuticals OY | AIM | £72.29M | 35.30 | 1.10% | |
| EAH | Eco Animal Health Group | AIM | £65.05M | 95.00 | -4.30% | |
| POLB | Poolbeg Pharma | AIM | £63.37M | 8.40 | -2.10% | |
| OBI | Ondine Biomedical Inc | AIM | £53.51M | 10.25 | 2.60% | |
| ANIC | Agronomics | AIM | £53.09M | 4.90 | -0.60% | |
| STX | Shield Therapeutics | AIM | £49.86M | 4.65 | -7.90% | |
| ABDX | Abingdon Health | AIM | £47.86M | 11.00 | 2.60% | |
| HVO | Hvivo | AIM | £45M | 6.40 | -5.10% | |
| SAR | Sareum Holdings | AIM | £44.34M | 31.50 | -5.60% | |
| AREC | Arecor Therapeutics | AIM | £30.58M | 85.00 | -1.30% | |
| SBTX | SkinBioTherapeutics | AIM | £23.97M | 9.50 | -14.90% | |
| IMM | ImmuPharma | AIM | £22.46M | 3.50 | -3.00% | |
| GDR | Genedrive | AIM | £20.87M | 1.25 | -1.60% | |
| EDEN | Eden Research | AIM | £17.67M | 2.15 | -2.40% | |
| IXI | Ixico | AIM | £16.35M | 7.85 | -1.50% | |
| OBD | Oxford BioDynamics | AIM | £15.46M | 0.11 | -4.00% | |
| CEL | Celadon Pharmaceuticals | AIM | £9.23M | 13.40 | % | |
| AGL | Angle | AIM | £7.72M | 2.40 | -0.70% | |
| OPTI | OptiBiotix Health | AIM | £6.56M | 6.35 | -3.30% | |
| TRX | Tissue Regenix Group | AIM | £5.16M | 7.25 | -1.50% | |
| VRCI | Verici Dx | AIM | £5.15M | 0.20 | -4.80% | |
| PRM | Proteome Sciences | AIM | £4.91M | 1.40 | 8.00% | |
| VAL | ValiRx | AIM | £1.91M | 0.14 | -2.20% | |
| FUM | Futura Medical | AIM | £1.45M | 0.23 | 14.60% | |
| GUN | Gunsynd | AIM | £1.33M | 0.09 | 9.50% |